Oppenheimer & Co. Inc. Acquires 13,362 Shares of SPDR S&P Biotech ETF $XBI

Oppenheimer & Co. Inc. grew its holdings in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) by 21.2% during the third quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 76,486 shares of the exchange traded fund’s stock after purchasing an additional 13,362 shares during the quarter. Oppenheimer & Co. Inc.’s holdings in SPDR S&P Biotech ETF were worth $12,060,000 as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors and hedge funds have also modified their holdings of the company. Park Avenue Securities LLC increased its position in SPDR S&P Biotech ETF by 10.8% during the third quarter. Park Avenue Securities LLC now owns 3,326 shares of the exchange traded fund’s stock worth $524,000 after buying an additional 323 shares during the last quarter. National Wealth Management Group LLC acquired a new stake in shares of SPDR S&P Biotech ETF in the third quarter worth about $609,000. Flagship Harbor Advisors LLC lifted its position in shares of SPDR S&P Biotech ETF by 10.4% in the third quarter. Flagship Harbor Advisors LLC now owns 9,283 shares of the exchange traded fund’s stock worth $1,464,000 after buying an additional 875 shares during the last quarter. Kingswood Wealth Advisors LLC lifted its position in shares of SPDR S&P Biotech ETF by 33.7% in the third quarter. Kingswood Wealth Advisors LLC now owns 19,218 shares of the exchange traded fund’s stock worth $3,030,000 after buying an additional 4,848 shares during the last quarter. Finally, Sigma Planning Corp lifted its position in shares of SPDR S&P Biotech ETF by 525.7% in the third quarter. Sigma Planning Corp now owns 13,077 shares of the exchange traded fund’s stock worth $2,062,000 after buying an additional 10,987 shares during the last quarter.

SPDR S&P Biotech ETF Stock Performance

XBI opened at $154.84 on Wednesday. The company has a market cap of $10.80 billion, a PE ratio of 11.47 and a beta of 0.83. The stock has a 50-day moving average of $157.04 and a 200-day moving average of $141.08. SPDR S&P Biotech ETF has a 52-week low of $106.30 and a 52-week high of $169.89.

SPDR S&P Biotech ETF Company Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index.